Clinical trial
Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in…
NCT00006234 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006234 |
|---|---|
| Title | Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone |
| Official title | A Phase I/II Study of 166Ho-DOTMP With Peripheral Blood Progenitor Cell Support for Refractory or Recurrent Ewing's Sarcoma Family of Tumors With Bone Disease |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer, Sarcoma |
| Intervention type | Procedure, Radiation |
| Interventions | peripheral blood stem cell transplantation, holmium Ho 166 DOTMP |
| Start date | Nov 1, 2001 |
| Completion | Mar 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 1, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: